Join to View Full Profile
617 W End AveSte 1BNew York, NY 10024
Phone+1 212-579-0339
Fax+1 212-543-5437
Dr. Sullivan is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
- New York Presbyterian Hospital (Columbia Campus)/New York State Psychiatric InstituteResidency, Psychiatry, 1994 - 1997
- New York Presbyterian Hospital (Columbia Campus)Internship, Internal Medicine, 1992 - 1993
- Columbia University Vagelos College of Physicians and SurgeonsClass of 1992
Certifications & Licensure
- NY State Medical License 1995 - 2026
Clinical Trials
- BEdtime Sublingual TNX-102 SL as Fibromyalgia Intervention Therapy (BESTFIT) Start of enrollment: 2013 Sep 01
- 12-Month Open-Label Long-term Safety Study of TNX-102 SL Tablets in Fibromyalgia Patients Start of enrollment: 2013 Dec 01
- Safety and Efficacy Study of TNX-102 SL in Subjects With Military-Related PTSD and Related Conditions Start of enrollment: 2014 Oct 01
- Join now to see all
Publications & Presentations
PubMed
- 2 citationsA phase 3, randomized, placebo-controlled, trial to evaluate the efficacy and safety of bedtime sublingual cyclobenzaprine (TNX-102 SL) in military-related posttraumat...Megan E Parmenter, Seth Lederman, Frank W Weathers, Lori L Davis, Benjamin Vaughn
Psychiatry Research. 2024-04-01 - 4 citationsAntisuicidal effect of lithum in bipolar disorder: is there an age-specific effect?Kanita Dervic, Leo Sher, Hanga C Galfalvy, Michael Grunebaum, Ainsley K Burke
Journal of Affective Disorders. 2023-11-15 - 4 citationsPredictors of Response to Prolonged Exposure, Sertraline, and Their Combination for the Treatment of Military PTSD.Sheila A.M. Rauch, H. Myra Kim, Seth Lederman, Gregory M. Sullivan, Ron Acierno
The Journal of Clinical Psychiatry. 2021-06-15
Press Mentions
- Tonix Pharmaceuticals Presented Results from Pharmacokinetic Analyses of TNX-102 SL in a Poster Presentation at the American Society of Clinical PsychopharmacologyMay 30th, 2019
- Tonix Pharmaceuticals Will Present Phase 3 HONOR and Phase 2 AtEase Study Results in a Poster Presentation at the 2018 Military Health System Research SymposiumAugust 15th, 2018
- Tonix Pharmaceuticals to Present Additional Clinical Results of Military-Related PTSD Study at the 2017 American Society of Clinical Psychopharmacology Annual MeetingMay 24th, 2017
Grant Support
- Development of TNX-1300 (Double Mutant Cocaine Esterase) for the Treatment of Life-Threatening Cocaine IntoxicationTONIX PHARMACEUTICALS, INC.2022–2025
- Brain Pathophysiology In Anxiety DisordersNational Institute Of Mental Health2004–2008
Professional Memberships
- Society for Biological PsychiatryMember
- Society for NeuroscienceMember
- American Society of Clinical PsychopharmacologyMember
Industry Relationships
- Chief Medical Officer, Tonix Pharmaceuticals2014 - Present
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
